Repare Therapeutics Inc. (RPTX:NASDAQ) closed at $2.65 on January 27, 2026, unchanged on the day. The stock trades 0.4% below its 52-week high of $2.66 and 197.8% above its 52-week low of $0.890. Repare Therapeutics Inc. is part of the Health Care sector.
In 252 trading sessions since October 15, 2025, RPTX closed higher on 32 days (13%). Its best day was November 17, 2025 (+32.12%) and its worst was October 27, 2025 (-4.59%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.
Repare Therapeutics Inc is a precision oncology company engaged in discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations.
Find more stocks like RPTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.